BCL2 and neoplasm: Cell experiments revealed that T‐miR‐149 significantly enhanced the apoptosis‐promoting ability of free miR‐149 in tumour cells through the Pi3k/Akt and Akt/Bcl‐2 pathways,45 and in vivo experiments further confirmed the antitumor efficacy of T‐miR‐149.